Cure Glaucoma Foundation

PROGRAMS
Research - Several unique research initiatives and partnerships are underway or in development (partial list):
-NT-501 Cell Therapy for the Treatment of Glaucoma - the goal of this study is to use a nerve growth factor, called ciliary neurotrophic factor (CNTF), to regenerate nerve tissue damaged from glaucoma.
- American Glaucoma Society MAPS Grant – 2020 marks the sixth year CGF has funded the AGS MAPS Program. This program supports early career glaucoma specialists and scientists by providing tools and resources to further their careers as potential leaders in the science, research and the specialty of glaucoma care.
- Akron Children’s Hospital Clinical Research: Development of an enzyme replacement therapy for primary congenital glaucoma (PCG) – The long-term goal of this project is to develop an Enzyme Replacement Therapy for the treatment of PCG using recombinant CYP1B1. A readily available efficacious and safe alternative method is critically needed to improve patient outcomes and their quality of life.

Global Outreach - CGF sponsors Medical Mission Trips to provide care for patients in underserved countries.
The GDD (Glaucoma Drainage Device) program is designed to teach qualified ophthalmologists in those countries how to implant the drain and, within 18 months, they will in turn train another physician in their resident country how to do the same. By this process CGF, in partnership with New World Medical, will greatly expand access to effective glaucoma therapy for many people.

Access to Care - The purpose of the Access to Care Project (ACP) is to take a proactive approach to reduce the burden of blindness. ACP is designed to address the unmet needs of persons affected by glaucoma with limited financial resources. Patient care provided will include eye exams, surgical, and postoperative clinical care necessary to prevent disease progression and blindness.

CGF has grown steadily thanks to the volunteer efforts and support of physicians, researchers and donors around the country. In addition, we have developed collaborative relationships with medical institutions around the world and partnerships within the medical industry stateside.

Cure Glaucoma Foundation
Pioneering Research & Providing Care

Mission Impact

Since our inception here is a summary of what your support and donations have accomplished:

Including industry backing from pharmaceutical and surgical supply companies (providing in-kind support), and direct financial donations from all of you.

Over the course of 12 mission trips and disaster relief programs there have been:

• 105 glaucoma drainage device implant surgeries performed
• 232 additional surgeries is performed
• 457 physicians and medical staff trained
• 8498 patients have been served
• and a total of $3.5 million in pharmaceutical and surgical supplies, and financial support provided for these trips.
On the research side CGF has funded 10 different initiatives including 8 research studies: 7 of the 8 have yielded favorable results, the total funding has been $307,000.
These programs are possible because of your thoughtful support. Thank you! Sincerely,

Steve Love,
Board President

Mike Kettles,
Executive Director